SIRT2 Regulates EX VIVO PBMC Adhesion in Septic Shock Patients

Deepmala Shrestha1, Bishnu Pant1, Akash Ahuja1

  • 1Inflammation and Immunity, Cleveland Clinic Lerner Research Institute, Cleveland, Ohio.

Shock (Augusta, Ga.)
|December 29, 2025
PubMed
Summary

Septic shock (SS) involves immune cells becoming hypo-inflammatory. High SIRT2 expression in SS patients impairs immune cell function, but inhibition may offer a therapeutic strategy for sepsis-induced hypo-inflammation.